| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $419.8M | +17.8% |
| R&D Expense | $117.4M | +4.5% |
| SG&A Expense | $76.6M | -4.2% |
| Operating Income | -$58.1M | +57.4% |
| Pre-tax Income | -$55.8M | +58.8% |
| Income Tax | $2.7M | +76.0% |
| Net Income | -$58.5M | +57.2% |
| EPS (Basic) | -$1.02 | +59.4% |
| EPS (Diluted) | -$1.02 |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.2M | -3.8% |
| Accounts Receivable | $73.6M | +13.5% |
| Current Assets | $203.3M | +3.9% |
| Total Assets | $388.4M | +4.9% |
| Current Liabilities | $114.0M | +3.5% |
| Long-term Debt | $1.9M | -38.4% |
| Total Liabilities | $123.6M | +4.0% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.4M | +200.0% |
| Capital Expenditures | $8.7M | +50.0% |
| Investing Cash Flow | -$24.1M | +39.3% |
| Financing Cash Flow | -$11.5M | +32.9% |
| Free Cash Flow | $23.7M | +162.0% |
| +59.4% |
| Stockholders' Equity |
| $264.8M |
| +5.3% |